Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Temmy Sunyoto, Julien Potet, Marleen Boelaert

Journal title: BMJ Global Health

Journal number: 3/3

Journal publisher: BMJ Publishing Group

Published year: 2018

Published pages: e000709

DOI identifier: 10.1136/bmjgh-2018-000709

ISSN: 2059-7908